• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓栓塞相关基因变异、凝血因子水平与凝血酶生成潜能之间的关联。

Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potential.

作者信息

Han Jihee, Li-Gao Ruifang, de Mutsert Renée, Rosendaal Frits R, van Hylckama Vlieg Astrid

机构信息

Department of Clinical Epidemiology Leiden University Medical Center Leiden the Netherlands.

出版信息

EJHaem. 2024 Feb 18;5(1):47-54. doi: 10.1002/jha2.863. eCollection 2024 Feb.

DOI:10.1002/jha2.863
PMID:38406509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10887265/
Abstract

Recently three large meta-analyses of genome-wide association studies for venous thromboembolism (VTE) identified over 130 genetic variants. However, mechanisms by which newly identified and therefore underexplored VTE-associated genetic variants influence VTE remain unclear. To elucidate the mechanism, we investigated the association between 61 newly identified VTE-associated genetic variants and the levels of coagulation factor (F) VIII, FIX, FXI, and fibrinogen as well as thrombin generation parameters (lag time, peak, endogenous thrombin potential, time-to-peak, and velocity), which are well-known biological traits associated with VTE. This study was conducted on 5341 participants of the Netherlands Epidemiology of Obesity study. The associations between VTE-associated genetic variants and coagulation factor levels and thrombin generation parameters were examined using linear regression analyses, adjusted for age, sex, body mass index, oral contraceptive use, hormone replacement therapy, and menopausal status. Of 61 genetic variants, 33 were associated with one or more of the coagulation factor levels and thrombin generation parameters. Following multiple testing corrections, five genetic variants remained significant, of which rs55707100 exhibited the most robust association with thrombin generation parameters and FXI levels (β = -5.33%, 95% confidence interval: -8.44, -2.22). Our findings shed light on the underlying mechanisms by which these genetic variants influence the risk of VTE.

摘要

最近,三项针对静脉血栓栓塞症(VTE)的全基因组关联研究的大型荟萃分析确定了130多个基因变异。然而,新发现的、因此尚未充分研究的VTE相关基因变异影响VTE的机制仍不清楚。为了阐明该机制,我们研究了61个新发现的VTE相关基因变异与凝血因子(F)VIII、FIX、FXI和纤维蛋白原水平以及凝血酶生成参数(滞后时间、峰值、内源性凝血酶潜力、达到峰值的时间和速度)之间的关联,这些都是与VTE相关的众所周知的生物学特征。这项研究是在5341名荷兰肥胖流行病学研究参与者中进行的。使用线性回归分析检查VTE相关基因变异与凝血因子水平和凝血酶生成参数之间的关联,并对年龄、性别、体重指数、口服避孕药使用、激素替代疗法和绝经状态进行了调整。在61个基因变异中,33个与一种或多种凝血因子水平和凝血酶生成参数相关。经过多次检验校正后,五个基因变异仍然显著,其中rs55707100与凝血酶生成参数和FXI水平表现出最强的关联(β = -5.33%,95%置信区间:-8.44,-2.22)。我们的研究结果揭示了这些基因变异影响VTE风险的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b44/10887265/96ec143481e2/JHA2-5-47-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b44/10887265/96ec143481e2/JHA2-5-47-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b44/10887265/96ec143481e2/JHA2-5-47-g001.jpg

相似文献

1
Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potential.静脉血栓栓塞相关基因变异、凝血因子水平与凝血酶生成潜能之间的关联。
EJHaem. 2024 Feb 18;5(1):47-54. doi: 10.1002/jha2.863. eCollection 2024 Feb.
2
Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.峰值凝血酶生成与随后的静脉血栓栓塞:血栓形成病因的纵向研究(LITE 研究)。
J Thromb Haemost. 2009 Oct;7(10):1639-48. doi: 10.1111/j.1538-7836.2009.03561.x. Epub 2009 Jul 28.
3
Associations of coagulation parameters and thrombin generation potential with the incidence of type 2 diabetes: mediating role of glycoprotein acetylation.凝血参数和凝血酶生成潜力与 2 型糖尿病发病的相关性:糖蛋白乙酰化的中介作用。
Eur J Epidemiol. 2024 Oct;39(10):1171-1181. doi: 10.1007/s10654-024-01162-0. Epub 2024 Oct 15.
4
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.瑞舒伐他汀可降低静脉血栓栓塞患者的凝血酶生成潜能:一项随机对照试验。
J Thromb Haemost. 2019 Feb;17(2):319-328. doi: 10.1111/jth.14364. Epub 2019 Feb 3.
5
Early thrombin formation capacity in trauma patients and association with venous thromboembolism.创伤患者早期凝血酶生成能力与静脉血栓栓塞的关系。
Thromb Res. 2016 Nov;147:13-15. doi: 10.1016/j.thromres.2016.09.024. Epub 2016 Sep 20.
6
Thrombin generation as an intermediate phenotype for venous thrombosis.凝血酶生成作为静脉血栓形成的中间表型。
Thromb Haemost. 2010 Jan;103(1):114-22. doi: 10.1160/TH09-06-0356. Epub 2009 Nov 13.
7
Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.凝血因子水平升高会影响凝血酶生成中的组织因子阈值。
Thromb Res. 2018 Dec;172:104-109. doi: 10.1016/j.thromres.2018.10.020. Epub 2018 Oct 25.
8
Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.静脉血栓栓塞症的诊断标志物:D-二聚体、凝血酶生成、促凝血磷脂和可溶性 P-选择素。
J Clin Pathol. 2018 Nov;71(11):1015-1022. doi: 10.1136/jclinpath-2018-205293. Epub 2018 Aug 9.
9
Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.标准化活化蛋白C比值本身与静脉血栓栓塞风险增加无关。
Contraception. 1998 Nov;58(5):321-2. doi: 10.1016/s0010-7824(98)00111-5.
10
Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism: first study from India.印度北部静脉血栓栓塞患者的凝血因子VIII、IX和XI水平:印度的首次研究。
Blood Coagul Fibrinolysis. 2016 Jan;27(1):58-63. doi: 10.1097/MBC.0000000000000390.

本文引用的文献

1
Sex-specific association between microvascular health and coagulation parameters: the Netherlands Epidemiology of Obesity study.微血管健康与凝血参数的性别特异性关联:荷兰肥胖症流行病学研究。
J Thromb Haemost. 2023 Sep;21(9):2585-2595. doi: 10.1016/j.jtha.2023.06.001. Epub 2023 Jun 8.
2
Effect of high-dose statin therapy on coagulation factors: Lowering of factor XI as a modifier of fibrin clot properties in coronary artery disease.大剂量他汀类药物治疗对凝血因子的影响:降低 XI 因子作为冠心病纤维蛋白栓特性的调节剂。
Vascul Pharmacol. 2023 Apr;149:107153. doi: 10.1016/j.vph.2023.107153. Epub 2023 Feb 11.
3
Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.
跨种族静脉血栓栓塞症基因组预测因子研究。
Circulation. 2022 Oct 18;146(16):1225-1242. doi: 10.1161/CIRCULATIONAHA.122.059675. Epub 2022 Sep 26.
4
Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis.FXI 活性与静脉血栓形成中的血栓炎症、细胞外基质、脂质代谢和细胞凋亡的关系。
Sci Rep. 2022 Jun 13;12(1):9761. doi: 10.1038/s41598-022-13174-5.
5
Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis.药物抑制凝血因子 XI 可减少血栓形成小鼠模型中的巨噬细胞积累并加速深静脉血栓溶解。
J Thromb Haemost. 2022 Sep;20(9):2035-2045. doi: 10.1111/jth.15777. Epub 2022 Jul 18.
6
Genetic analysis of over half a million people characterises C-reactive protein loci.对超过 50 万人的基因分析确定了 C 反应蛋白基因座。
Nat Commun. 2022 Apr 22;13(1):2198. doi: 10.1038/s41467-022-29650-5.
7
Boosting Schizophrenia Genetics by Utilizing Genetic Overlap With Brain Morphology.利用与大脑形态学的遗传重叠来提高精神分裂症遗传学研究。
Biol Psychiatry. 2022 Aug 15;92(4):291-298. doi: 10.1016/j.biopsych.2021.12.007. Epub 2022 Feb 11.
8
D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly.D-二聚体、凝血酶生成与老年人首次发生静脉血栓形成的风险
Res Pract Thromb Haemost. 2021 Jun 21;5(5):e12536. doi: 10.1002/rth2.12536. eCollection 2021 Jul.
9
Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study.他汀类药物使用对凝血标志物的差异效应:NEO研究中的一项活性对照分析。
Thromb J. 2021 Jun 27;19(1):45. doi: 10.1186/s12959-021-00299-2.
10
Understanding the genetic determinants of the brain with MOSTest.用 MOSTest 理解大脑的遗传决定因素。
Nat Commun. 2020 Jul 14;11(1):3512. doi: 10.1038/s41467-020-17368-1.